The estimated Net Worth of Jeffrey A Rideout is at least $1.2 Million dollars as of 13 December 2019. Jeffrey Rideout owns over 600 units of Amedisys stock worth over $125,446 and over the last 9 years he sold AMED stock worth over $812,712. In addition, he makes $261,589 as Independent Director at Amedisys.
Sign up
Jeffrey Rideout AMED stock SEC Form 4 insiders trading
Jeffrey has made over 4 trades of the Amedisys stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 600 units of AMED stock worth $96,648 on 13 December 2019.
The largest trade he's ever made was selling 3,657 units of Amedisys stock on 7 June 2019 worth over $424,322. On average, Jeffrey trades about 450 units every 35 days since 2016. As of 13 December 2019 he still owns at least 1,297 units of Amedisys stock.
You can see the complete history of Jeffrey Rideout stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jeffrey Rideout biography
Dr. Jeffrey A. Rideout M.D., is Independent Director of the Company. He is President and Chief Executive Officer of the Integrated Healthcare Association, a California statewide multi-stakeholder leadership group that promotes quality improvement, accountability and affordability of health care. He joined Integrated Healthcare Association in May of 2015. Dr. Rideout holds academic appointments with Stanford University (since January 2014) and University of California Berkeley Haas School of Business (since January 2008, and previously from January 2002 to January 2004), teaching on topics related to healthcare technology, services and investment. Previously, from June 2013 until June 2015, Dr. Rideout served as the Senior Medical Advisor for Covered California, the state based insurance exchange for California, and was responsible for quality and network management and all physician and hospital relations. Dr. Rideout has also served as a Senior Advisor to GE Healthcare Ventures, focusing on new business development related to Digital Health and Digital Therapeutics, including assessing and accelerating new early stage solutions and companies. From July 2009 until June 2013, Dr. Rideout was Senior Vice President, Chief Medical Officer for The TriZetto Group, leading strategy around development and delivery of a comprehensive suite of products and services that enable payers, providers and employers to improve the cost and quality of care for consumers. Dr. Rideout also served as the global leader of the healthcare division for Cisco Systems Internet Business Solutions Group, and Cisco’s Chief Medical Officer. While at Cisco, Dr. Rideout also served as a member of the American Health Information Community (AHIC’s) Chronic Care Workgroup for the US Department of Health and Human Services. Dr. Rideout was at Cisco from April 2004 to August 2007.
What is the salary of Jeffrey Rideout?
As the Independent Director of Amedisys, the total compensation of Jeffrey Rideout at Amedisys is $261,589. There are 14 executives at Amedisys getting paid more, with Paul Kusserow having the highest compensation of $12,835,500.
How old is Jeffrey Rideout?
Jeffrey Rideout is 58, he's been the Independent Director of Amedisys since 2016. There are 6 older and 11 younger executives at Amedisys. The oldest executive at Amedisys Inc. is Molly Coye, 72, who is the Independent Director.
What's Jeffrey Rideout's mailing address?
Jeffrey's mailing address filed with the SEC is 3854 AMERICAN WAY, SUITE A, , BATON ROUGE, LA, 70816.
Insiders trading at Amedisys
Over the last 27 years, insiders at Amedisys have traded over $269,564,877 worth of Amedisys stock and bought 2,690,968 units worth $38,198,016 . The most active insiders traders include Asset Management Llc Kohlbe..., Tide Capital, Llc North Tid... und David Nierenberg. On average, Amedisys executives and independent directors trade stock every 29 days with the average trade being worth of $2,494,602. The most recent stock trade was executed by Richard M Ashworth on 26 December 2023, trading 11,237 units of AMED stock currently worth $896,937.
What does Amedisys do?
amedisys is a leading provider of healthcare in the home with a vision of becoming the premiere solution for patients across the country to age in place. from home health to hospice to personal care, amedisys team members provide quality, clinically-distinctive care to more than 376,000 patients every year. every life is precious and tells an incredible story, and we celebrate that each day by honoring our patients with genuine, personal attention. everything we do, from the boardroom to our nationwide network of care centers, is centered on the best care possible for those who have entrusted us with their well-being and comfort. we work closely with doctors and other healthcare providers to coordinate services, and every patient has an individual plan of care that meets their specific needs. amedisys recognizes that nothing we do is possible without our incredible team. for all employees, whether they’re on the front lines delivering direct care or supporting our clinical team, this i
What does Amedisys's logo look like?
Complete history of Jeffrey Rideout stock trades at Amedisys und HMS Corp
Amedisys executives and stock owners
Amedisys executives and other stock owners filed with the SEC include:
-
Paul Kusserow,
Chairman of the Board, President, Chief Executive Officer -
Christopher Gerard,
Chief Operating Officer -
Scott Ginn,
Chief Financial Officer -
Sharon Brunecz,
Chief Human Resource Officer -
David Kemmerly,
Chief Legal and Government Affairs Officer -
Paul Berthold Kusserow,
Chairman & CEO -
Michael North,
Chief Information Officer -
Christopher T. Gerard,
Pres, COO & Director -
Scott G. Ginn,
Exec. VP & CFO -
David L. Kemmerly,
Chief Legal & Gov. Affairs Officer -
Sharon Brunecz,
Chief HR Officer -
Julie Klapstein,
Independent Director -
Richard Lechleiter,
Lead Independent Director -
Bruce Perkins,
Independent Director -
Jeffrey Rideout,
Independent Director -
Teresa Kline,
Independent Director -
Molly Coye,
Independent Director -
Vickie Capps,
Independent Director -
Nick Muscato,
Vice President of Strategic Finance -
Denise Bohnert,
Chief Compliance Officer -
Janet Britt,
Sr. VP of Billing & Collections -
Adam Holton,
Chief People Officer -
Jennifer Guckert Griffin,
Sr. VP, Deputy Gen. Counsel, Corp. Sec. & Interim Chief Legal Officer -
John Nugent,
Chief Acquisitions Officer -
Kendra Kimmons,
VP of Marketing & Communications -
Denise Bohnert,
Chief Compliance Officer -
Michael P. North,
Chief Information Officer -
Pete Hartley,
CTO & Sr. VP of Bus. Operations Systems -
Jake L Netterville,
Director -
Jeffrey D Jeter,
Chief Compliance Officer -
Donald A Washburn,
Director -
Nathaniel M Zilkha,
Director -
David B. Pearce,
Chief Compliance Officer -
Lawrence R Pernosky,
Chief Human Resources Officer -
Martin B Howard,
Chief Information Officer -
Ronald A Laborde,
Director -
Stephen Seim,
Chief Strategy Officer -
Gary D Willis,
Chief Financial Officer -
Linda J. Hall,
Director -
Jane Carmody,
See Remarks -
Daniel P Mc Coy,
Chief Operating Officer -
Alice A Schwartz,
CIO -
Susan Sender,
See Remarks -
Asset Management Llc Kohlbe...,
-
Allyson Guidroz,
Chief Accounting Officer -
Richard M Ashworth,
President and CEO -
Larry R Graham,
COO -
Donald Jr Loverich,
Principal Accounting Officer -
John F Giblin,
Chief Financial Officer -
Gregory H Browne,
Chief Financial Officer -
David Nierenberg,
10% owner -
John Hank Linden,
Chief Information Officer -
Listed Ltd Terra,
10% owner -
Tide Capital, Llc North Tid...,
-
Peter Ricchiuti,
Director -
Michael O. Fleming,
Chief Medical Officer -
David R Bucey,
General Counsel and Secretary -
David R Pitts,
Director -
William F Borne,
CEO -
T A Jr Barfield,
Chief Development Officer -
Dale E Redman,
Chief Financial Officer -
Michael D Snow,
Chief Operating Officer -
Ivanetta Davis Samuels,
Director -
Adam Y Holton,
Chief People Officer